Thailand
+919405476170

Cizumab 400mg Injection Dealer, Supplier, Dis...

update image
Cizumab 400mg Injection Dealer, Supplier, Distributor, Exporter, Source, Authorized Distributor, Channel Partner, Vendor Ernest Pharmaceutical is leading exporter of Cizumab 400mg Injection in Canberra, Melbourne, Sydney, Washington, California, Texas, Riyadh, Jeddah, Buraydah, Tabuk, London, Birmingham, Bristol, Plymouth, Bangkok, Thailand Cizumab 400mg Injection - Ernest Pharmaceutical Are you looking for Cizumab 400mg Injection exporter from india? Contact - https://www.ernestimpex.com SALT COMPOSITION – Cizumab 400mg Injection (Bevacizumab 400mg) Storage - Store in a refrigerator (2 - 8°C). Do not freeze. Product Brochure Packaging Size - 1 box content 1 vial Usage/Application - Hospital Brand - Cizumab 400mg Injection (Bevacizumab 400mg) Composition - Cizumab 400mg Injection (Bevacizumab 400mg) Form - Injection Shelf Life - 24 Months Marketed By - ERNEST Country of Origin - Made in India Minimum order quantity - 10 Box Uses of Cizumab Solution for Infusion Cancer of colon and rectum Non-small cell lung cancer Cervical cancer Ovarian cancer Cancer of fallopian tube Brain tumor Kidney cancer Product introduction Cizumab 400 Solution for Infusion is an anticancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing. Cizumab 400 Solution for Infusion is an effective medicine, first-line option when used together with other cancer medicines. It is given as an infusion. That means you get it through a small needle in your vein or through a port, which is a device placed under your skin. The doctor will decide your dose and duration and will check you for signs of an infusion reaction such as high blood pressure and trouble breathing. You keep taking Cizumab 400 Solution for Infusion as long as your disease is controlled and your side effects are manageable. Your doctor will determine whether you should stop taking it or not. You may be advised to check blood pressure and levels of protein in urine while you are taking this medication. The most common side effects of this medicine include nosebleeds, headache, high blood pressure, rhinitis, protein in urine, change in taste, dry skin, bleeding, lacrimation disorder, back pain, and exfoliative dermatitis. Inform your doctor that you are taking this medication before undergoing any surgical procedure, as the drug has ability to lower the ability of wound healing. Other than this, it also enhances your risk of bleeding thus if you notice any unusual bleeding or bleeding consult with your doctor immediately. Inform your doctor if you are pregnant, planning pregnancy or breastfeeding. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. Side effects of Cizumab Solution for Infusion Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Cizumab Nosebleeds Headache High blood pressure Inflammation of the nose Protein in urine Taste change Dry skin Hemorrhage Increased lacrimation Back pain Exfoliative dermatitis www.ernestimpex.com www.ernestpharmaceuticals.com
 2025-05-17T14:30:04

Related Posts

update image

Ernest Pharmaceuticals – Trusted Medicine Exporter to Hong Kong & Global Markets

2025-08-11T12:52:21 , update date

 2025-08-11T12:52:21
update image

Buy Levocetirizine + Montelukast Tablets in Bulk in Hong Kong – WHO-GMP Certified Exporter

2025-08-11T11:46:07 , update date

 2025-08-11T11:46:07
update image

Buy Levocetirizine + Montelukast Tablets in Bulk – WHO-GMP Certified Exporter

2025-08-11T11:43:10 , update date

 2025-08-11T11:43:10
update image

Montelukast & Levocetirizine Tablets for Allergy & Asthma – International Exporter | Ernest

2025-08-11T11:40:24 , update date

 2025-08-11T11:40:24